Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.
Serous ovarian cancer (SeOvCa) is an aggressive disease with differential and often inadequate therapeutic outcome after standard treatment. The Cancer Genome Atlas (TCGA) has provided rich molecular and genetic profiles from hundreds of primary surgical samples. These profiles confirm mutations of...
Main Authors: | Parminder K Mankoo, Ronglai Shen, Nikolaus Schultz, Douglas A Levine, Chris Sander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3207809?pdf=render |
Similar Items
-
Genomic and Transcriptome Profiling of Serous Epithelial Ovarian Cancer
by: Menzies, Rebecca Joanne Zoe
Published: (2009) -
Genomic and Transcriptome Profiling of Serous Epithelial Ovarian Cancer
by: Menzies, Rebecca Joanne Zoe
Published: (2009) -
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.
by: Chad J Creighton, et al.
Published: (2012-01-01) -
MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
by: Yu X, et al.
Published: (2021-01-01) -
High levels of genomic aberrations in serous ovarian cancers are associated with better survival.
by: Lars O Baumbusch, et al.
Published: (2013-01-01)